The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the childhood cancer community to learn about CCDI programs and
At CAC2 we are focused on children with cancer, but the issues impacting them are wide ranging and often far bigger than what the childhood
If you weren’t able to join us for the “Know Before You Go” drop-in session for CAC2 Members it isn’t too late to catch up
There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years
During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on
The October 10 Federal Advocacy drop-in session covered three pieces of authorizing legislation and provided an update on possible appropriations for FY2025. Each of the
The NCI Council of Research Advocates met virtually on June 26 and heard the latest legislative report, with updates on appropriations, cancer-related legislation, and other
By CAC2 Member Matt Marks (Leukemia & Lymphoma Society) State borders shouldn’t be barriers to treatment for children with cancer or other complex illnesses. Yet
The Energy and Commerce Committee advanced proposals earlier this month that will extend Americans’ access to telehealth services, strengthen and preserve Medicaid, and encourage innovation
